1. DOJ Markers and Overlapping State Enforcement
The DOJ Antitrust Division uses markers to hold an applicant's place in line for a limited period while additional facts are investigated. State attorneys general may pursue related conduct under separate state authority, so federal leniency does not automatically determine state enforcement consequences.
First-in-Line Status and Conditional Leniency
A marker requires enough information to identify the suspected criminal antitrust conduct and distinguish the relevant conspiracy. Engaging a cross-border cartel leniency program consulting attorney helps assess marker timing while the company determines whether it can satisfy the conditions for corporate leniency.
Federal and State Enforcement Paths
State enforcement authority varies by jurisdiction and should not be treated as a uniform extension of the federal Leniency Program. An Antitrust Practice analysis can identify where federal self-disclosure may overlap with separate state investigations or private claims.
2. International Marker Timing and Disclosure Sequencing
A DOJ marker does not reserve priority before foreign competition authorities. Companies considering applications in several jurisdictions must compare eligibility rules, confidentiality protections, deadlines, and the information required by each authority.
Parallel U.S. and Foreign Leniency Applications
Information sufficient for one authority may not satisfy another jurisdiction's leniency requirements. A cross-border cartel leniency program consulting attorney can sequence applications without assuming that a federal marker creates equivalent priority abroad.
Marker Scope before a Full Corporate Proffer
The marker process gives counsel a limited period to investigate facts before completing the leniency application. That period can be used to define the suspected conspiracy, identify relevant personnel, preserve records, and determine whether additional jurisdictions require separate applications.
3. Corporate Leniency and Individual Executive Exposure
Corporate and individual interests may diverge when executives participated in the suspected conduct or possess evidence relevant to the application. The Sherman Act permits substantial criminal penalties for individuals, making conflict analysis important before interviews or substantive disclosures.
Separate Counsel and Employee Cooperation
Individual protection should not be assumed merely because the corporation seeks leniency. Counsel must examine the applicable DOJ policy, the individual's conduct, cooperation requirements, and whether separate representation is appropriate.
Internal Fact Development before Disclosure
Internal Investigation Services can help define who participated, what communications exist, and when the suspected conduct occurred. Interview protocols should also distinguish corporate representation from any separate interests of individual employees.
4. Criminal Leniency and Private Antitrust Damages
DOJ leniency concerns criminal prosecution, but private plaintiffs may pursue damages arising from the same cartel conduct. ACPERA can limit qualifying applicants' damages exposure when statutory requirements, including required cooperation with civil plaintiffs, are satisfied.
| Proceeding | Primary Issue | Leniency Consideration |
|---|---|---|
| DOJ Criminal Investigation | Criminal cartel liability | Marker and conditional leniency requirements |
| State Enforcement | Separate state authority | Jurisdiction-specific treatment |
| Private Civil Litigation | Antitrust damages | Potential ACPERA limitation if statutory conditions are met |
DOJ Criminal Investigation
- Primary IssueCriminal cartel liability
- Leniency ConsiderationMarker and conditional leniency requirements
State Enforcement
- Primary IssueSeparate state authority
- Leniency ConsiderationJurisdiction-specific treatment
Private Civil Litigation
- Primary IssueAntitrust damages
- Leniency ConsiderationPotential ACPERA limitation if statutory conditions are met
ACPERA and the Limits of a Marker
A marker alone is not a currently effective antitrust leniency agreement for ACPERA purposes. A qualifying applicant must satisfy the applicable statutory requirements, including cooperation obligations in the related civil action, before the damages limitation can apply.
Parallel Class Action Strategy
Criminal cooperation may generate facts relevant to later civil proceedings, so disclosure decisions should account for both enforcement and litigation consequences. The timing and scope of factual submissions should be reviewed separately from the merits of any private damages defense.
5. Preserving Privilege during Leniency Cooperation
Leniency cooperation requires substantial factual disclosure, but it does not make every privileged communication or attorney work product automatically discoverable. The company should distinguish underlying facts from protected legal communications when collecting, reviewing, and presenting investigation material.
Preserving Privilege Across Jurisdictions
Privilege rules can differ when documents, employees, and counsel are located in several countries. Investigations, Compliance & Ethics review can address interview protocols, document handling, and disclosure boundaries before information moves between proceedings.
Cooperation without Assuming Waiver
Counsel should evaluate the legal effect of each proposed disclosure rather than assuming that cooperation requires a broad privilege waiver. The analysis may include who created the material, its purpose, the authority receiving it, and how later litigants could seek access.
6. Frequently Asked Questions
Does a DOJ marker confer immediate corporate leniency?
No. A marker temporarily holds an applicant's place in line while it develops information needed to complete the application. The applicant must still satisfy the Leniency Policy requirements.
Can a DOJ marker provide priority before foreign competition authorities?
No. A DOJ marker applies to the Antitrust Division's process and does not establish priority under another jurisdiction's leniency program.
Does federal leniency eliminate private antitrust damages claims?
No. Private claims may continue, although ACPERA can limit recoverable damages against a qualifying leniency applicant that satisfies the statute's cooperation requirements.
18 Aug, 2026
